Eli Lilly and Co

Novo CEO Mike Doustdar told CNBC that the pharmaceutical giant is considering M&A opportunities as it faces…
Read More...

People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen,…
Read More...

Jim's current faves include three tech names and a bank stock. Read More: Here’s a rapid-fire update on our…
Read More...

CONCORD, N.C. – Rachel Wagoner describes Concord, North Carolina, as the kind of place where she always envisioned…
Read More...

Blood sample for a lipoprotein(a) test.Md Babul Hosen | Istock | Getty ImagesNovartis' failure in a closely watched…
Read More...

U.S. President Donald Trump delivers remarks on his administration's healthcare policies, in the Oval Office at the…
Read More...

Hims & Hers CEO Andrew Dudum defended the telehealth company amid a Federal Trade Commission lawsuit over its…
Read More...

CNBC's Jim Cramer said Thursday earnings season has revealed investing themes he thinks will produce the market's…
Read More...

Cardinal Health on Tuesday showed why the healthcare distributor belongs in our portfolio, delivering robust…
Read More...

Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S., allowing it to compete…
Read More...